<DOC>
	<DOC>NCT01877902</DOC>
	<brief_summary>STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM</brief_summary>
	<brief_title>Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Patients over 18 years Confirmed diagnosis of metastatic NSCLC Pemetrexed Starts 1st line (either induction or maintenance) in any of the following periods: January 1, 2010 to March 31, 2010 October 1, 2011 to December 31, 2011 Patients receiving pemetrexed within a clinical trial protocol because it is an experimental environment that does not reflect clinical practice.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>